Hydrocot and Trifluoperazine Tablets
Determining the interaction of Hydrocot and Trifluoperazine Tablets and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Using trifluoperazine together with hydroCHLOROthiazide can increase the risk of an irregular heart rhythm that may be serious. If your doctor prescribes these medications together, you may need regular monitoring of your electrolyte (magnesium, potassium) levels as well as other tests to safely use both medications. You should seek immediate medical attention if you develop sudden dizziness, lightheadedness, fainting, or fast or pounding heartbeats during treatment with trifluoperazine. In addition, you should let your doctor know if you experience signs of electrolyte disturbance such as weakness, tiredness, drowsiness, confusion, muscle pain, cramps, dizziness, nausea, or vomiting. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR: Some neuroleptic agents may cause prolongation of the QT interval. While clinical data are lacking, the coadministration of other agents that can produce hypokalemia and/or hypomagnesemia (e.g., potassium-wasting diuretics, amphotericin B, cation exchange resins, stimulant laxatives) may result in elevated risk of ventricular arrhythmias, including ventricular tachycardia and torsade de pointes. In addition, neuroleptic agents may potentiate the hypotensive effect of diuretics secondary to their peripheral alpha-1 adrenergic blocking activity. Orthostatic hypotension and syncope associated with vasodilation may occur, particularly during the initial dose titration period of neuroleptic therapy.
MANAGEMENT: Caution is advised when neuroleptics must be used concomitantly with medications that can cause potassium and/or magnesium disturbances. Serum electrolytes should be monitored and any abnormalities corrected prior to initiating therapy with a neuroleptic. Close clinical monitoring for development of hypotension is recommended if neuroleptic agents are prescribed with a diuretic medication. Patients should be advised to notify their physician if they experience dizziness, lightheadedness, syncope, orthostasis, or tachycardia. A lower starting dosage and slower titration of the neuroleptic agent may be appropriate in patients receiving antihypertensive therapy, especially if they are elderly.
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- Cerner Multum, Inc. "Australian Product Information." O 0
Generic Name: hydrochlorothiazide
Brand name: Aquazide H, HydroDIURIL, Microzide,
Synonyms: HCTZ, Hydrochlorothiazide
Generic Name: trifluoperazine
Brand name: Stelazine
Synonyms: Trifluoperazine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hydrocot-Trifluridine and Tipiracil
- Hydrocot-Trifluridine and Tipiracil Hydrochloride
- Hydrocot-Triglide
- Hydrocot-Trihexane
- Hydrocot-Trihexyphenidyl
- Hydrocot-Trihexyphenidyl Elixir
- Trifluoperazine Tablets-Hydrogen Peroxide
- Trifluoperazine Tablets-Hydrogen Peroxide 40%
- Trifluoperazine Tablets-Hydrogen Peroxide Oral Rinse
- Trifluoperazine Tablets-Hydrogen Peroxide Solution
- Trifluoperazine Tablets-Hydrogen Peroxide Solution (Seborrheic Keratoses)
- Trifluoperazine Tablets-Hydrogen peroxide Topical application